Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Oncology in Practice
  3. Palliative and Supportive care
  4. Multikinase Inhibitor-Related Skin Toxicity
  5. Healthcare Professionals
  6. Prophylaxis and Treatment
  7. Reactive management

Reactive management

Previous Page Next Page

Reactive management of papilloma and squamous cell carcinoma induced by multikinase inhibitor treatment

General recommendation: Early intervention is important.

Treatment

Refer to dermatologist for inspection of the skin, especially sun-exposed areas, and for appropriate treatment.

Multikinase inhibitor treatment

Continue with/withhold the selected multikinase inhibitor treatment regimen, as recommended in the current and relevant SPC and according to the patient’s condition.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.